EP 1037610 A1 20000927 - LIPOSOMAL CAMPTOTHECIN FORMULATIONS
Title (en)
LIPOSOMAL CAMPTOTHECIN FORMULATIONS
Title (de)
LIPOSOMALE CAMPTOTHECIN FORMULIERUNGEN
Title (fr)
COMPOSITIONS A BASE DE LIPOSOMES RENFERMANT DE LA CAMPTOTHECINE
Publication
Application
Priority
- US 9819086 W 19980915
- US 5908397 P 19970916
Abstract (en)
[origin: WO9913816A2] Liposomal encapsulated camptothecin formulations are provided. The liposomes have improved pharmacokinetics, enhanced efficacy as anti-tumor agents and provide an increased therapeutic index as compared to the free drug and topotecan. The formulations include liposomes comprising at least one phospholipid and a camptothecin or analog thereof.
IPC 1-7
IPC 8 full level
A61K 9/127 (2006.01); A61K 31/4745 (2006.01); A61K 31/496 (2006.01); A61K 47/04 (2006.01); A61K 47/12 (2006.01); A61K 47/16 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR)
A61K 9/127 (2013.01 - EP KR); A61K 9/1278 (2013.01 - EP); A61K 31/4745 (2013.01 - EP); A61K 31/496 (2013.01 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9913816 A2 19990325; WO 9913816 A3 20011101; AU 751439 B2 20020815; AU 9387798 A 19990405; BR 9812316 A 20010320; CA 2303366 A1 19990325; EP 1037610 A1 20000927; EP 1037610 A4 20040707; JP 2003510239 A 20030318; KR 100711315 B1 20070427; KR 20010030599 A 20010416; NZ 503293 A 20020927
DOCDB simple family (application)
US 9819086 W 19980915; AU 9387798 A 19980915; BR 9812316 A 19980915; CA 2303366 A 19980915; EP 98946983 A 19980915; JP 2000511445 A 19980915; KR 20007002701 A 20000315; NZ 50329398 A 19980915